Market Tracker

07/23 3:33am ET

Trovagene Inc (NASDAQ:TROV)

3.19
Data as of Jul 22
 +0.03 / +0.95%
Today’s Change
3.15
Today|||52-Week Range
10.27
-44.43%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close3.16
Today’s open3.24
Day’s range3.15 - 3.42
Volume85,259
Average volume (3 months)68,326
Market cap$59.9M
Dividend yield--
Data as of 4:00pm ET, 07/22/2014

Growth & Valuation

Earnings growth (last year)+21.35%
Earnings growth (this year)-20.95%
Earnings growth (next 5 years)--
Revenue growth (last year)-42.44%
P/E ratioNM
Price/Sales375.92
Price/Book2.94

Competitors

 Today’s
change
Today’s
% change
APPYVenaxis Inc+0.06+3.14%
GBIMGlobeImmune Inc-0.07-0.53%
LPDXLipoScience Inc-0.12-3.80%
PANGPanacea Global Inc+0.10+90.48%
Data as of 4:00pm ET, 07/22/2014

Financials

Next reporting dateAugust 14, 2014
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$259.2K
Annual profit (last year)-$11.8M
Net profit margin-4,555.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Antonius P. Schuh
Chief Financial Officer
Stephen L. Zaniboni
Corporate headquarters
San Diego, California

Forecasts